10-Q: Advanced Flower Capital Reports Q2 Loss Amid Credit Provisions

Advanced Flower Capital Inc. reported a significant net loss for Q2 2025, driven by increased credit loss provisions and lower interest income, while announcing a strategic shift towards becoming a Business Development Company (BDC).

Summary

• Reported a net loss from continuing operations of $13.2 million for the three months ended June 30, 2025, compared to a net income of $15.2 million for the same period in 2024.
• Basic earnings per common share from continuing operations was $(0.60) for Q2 2025, down from $0.74 in Q2 2024.
• Interest income decreased by 55.2% to $8.1 million for Q2 2025, primarily due to fewer loan exits and non-recurring income in the prior period, and lower interest income from nonaccrual loans.
• A significant provision for current expected credit losses of $15.9 million was recorded for Q2 2025, a substantial increase from a reversal of $6.3 million in Q2 2024, reflecting higher anticipated losses.
• Cash and cash equivalents decreased significantly to $3.4 million as of June 30, 2025, from $103.6 million at December 31, 2024.
• Total assets declined to $290.6 million as of June 30, 2025, from $402.1 million at December 31, 2024, partly due to the spin-off of the commercial real estate portfolio.
• The company declared total cash dividends of $0.38 per common share for the six months ended June 30, 2025, a decrease from $1.11 per share for the same period in 2024.
• Four loans, totaling $104.2 million in carrying value (for loans held at carrying value) and $51.2 million in outstanding principal (for the loan held at fair value), were on nonaccrual status as of June 30, 2025.
• The company is pursuing a conversion from a mortgage REIT to a Business Development Company (BDC) to broaden its investment universe beyond real estate-backed cannabis loans.
• The investment strategy has been expanded to include senior secured loans and debt securities to companies ancillary to the cannabis industry and companies outside of the cannabis industry.
• A $1.8 million equipment loan receivable with Public Company A was written off in Q2 2025, as it was deemed uncollectible.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a substantial net loss, a significant increase in credit loss provisions, and a sharp decline in interest income. While the strategic shift to a BDC and expanded investment mandate offers long-term potential, the immediate financial performance and liquidity position are concerning, compounded by ongoing legal challenges with key borrowers and a reduction in dividends.

Positives

• Expanded investment strategy to include ancillary cannabis businesses and companies outside the cannabis industry, leveraging the investment team's 30+ years of experience in direct lending.
• Pursuing BDC conversion, which, if approved by shareholders, will enable investment in a much broader universe of assets, including non-real estate covered vertically integrated operators.
• Successfully terminated the AFCF Credit Facility with an affiliate in April 2025, with no outstanding borrowings.
• Increased the Revolving Credit Facility commitment by $20.0 million to a total aggregate commitment of $50.0 million in June 2025.
• Maintained compliance with all material covenants of the Revolving Credit Agreement as of June 30, 2025.

Negatives

• Reported a net loss of $13.2 million for Q2 2025 and $9.1 million for the six months ended June 30, 2025, a significant decline from net income in the prior year periods.
• Interest income decreased by 55.2% for Q2 2025 and 48.9% for the six months ended June 30, 2025, primarily due to fewer loan exits and increased nonaccrual loans.
• Provision for current expected credit losses increased substantially to $15.9 million in Q2 2025, indicating higher anticipated loan defaults and losses.
• Cash and cash equivalents significantly decreased from $103.6 million at year-end 2024 to $3.4 million at June 30, 2025.
• Book value per share decreased to $8.18 as of June 30, 2025, from $9.02 at December 31, 2024.
• Dividends declared per common share for the six months ended June 30, 2025, were $0.38, a substantial reduction from $1.11 in the prior year period.
• Four loans, including Private Company A, Subsidiary of Private Company G, Private Company K, and Private Company P, are on nonaccrual status, impacting interest income.
• A $1.8 million equipment loan receivable was written off in Q2 2025 due to uncollectibility.
• Ongoing legal actions with Subsidiary of Private Company G and its shareholders, including a preliminary injunction granted against the company, create uncertainty and potential for further losses.

Risks

• Strict federal enforcement against cannabis borrowers due to federal illegality of cannabis, potentially impacting loan collectibility.
• Borrowers' inability to renew or maintain licenses or other requisite authorizations for cannabis operations.
• Lack of liquidity in cannabis loans, potentially leading to partial or complete loss of investments.
• Adverse changes in state or national laws/enforcement guidelines related to cannabis, impeding business growth.
• Prohibition from owning cannabis assets upon loan default or seizure, limiting ability to take possession of collateral and potentially resulting in losses on loan sales.
• Volatility of real property values, which could materially adversely affect business, financial position, and results of operations.
• Reductions in Net Operating Income (NOI) of commercial properties, increasing risks of delinquency, foreclosure, and default.
• Higher risks associated with lending to small and medium-sized, privately owned businesses due to limited capital access and weaker financial positions.
• Borrowers, owners, and tenants seeking bankruptcy protection, which may result in stays of legal proceedings, debt restructuring, or loss of cash collateral.
• Non-recourse nature of most commercial mortgage loans, meaning collateral may be insufficient to cover losses in case of default.
• Difficulty in selling collateral or realizing value from licenses, as regulatory approvals are required.
• Exposure to interest rate risk, where rising borrowing costs may outpace yields on fixed-rate assets or floating-rate assets with caps.
• Interest rate mismatch risk between loan assets and financing obligations, potentially impacting profitability.
• Concentration risk in the loan portfolio, with the top three borrowers representing 46.3% of outstanding principal balances.
• Industry consolidation among cannabis operators, which could further increase borrower concentration risk.

Future Outlook

The company intends to convert from a mortgage REIT to a Business Development Company (BDC), subject to shareholder approval, to significantly expand its investment universe to include both real estateand non-real estate-related assets. This strategic shift will allow lending to non-real estate covered vertically integrated cannabis operators and ancillary cannabis businesses. The company expects to file a preliminary proxy statement soon to seek shareholder approval for the new Investment Advisory Agreement and a reduction in the asset coverage ratio to utilize greater leverage. It also expects to need to raise additional equity and/or debt funds in the near future to support its expanded investment focus and increase liquidity.

Management Comments

• "By expanding the investment mandate, we expect to be able to diversify its exposure across industries and credit risk profiles while maintaining deal selectivity."
• "We believe there are also attractive lending opportunities in companies ancillary to and outside of the cannabis industry that could generate attractive risk-adjusted returns."
• "We believe that converting from a mortgage REIT to a BDC... would enable the Company to pursue a broader array of investment opportunities."
• "Given the capital-intensive nature of the cannabis industry, combined with the high cost of capital, many operators do not own real estate, which significantly limits the universe of cannabis operators to which the Company can lend as a mortgage REIT. The Conversion would allow the Company to invest in non-real estate covered vertically integrated operators."
• "If completed, the transition to a BDC will enable the Company to significantly expand its investment universe by increasing its ability to lend to ancillary cannabis businesses as well as non-real estate covered vertically integrated operators."
• "We expect we will need to raise additional equity and/or debt funds to increase our liquidity in the near future."

Industry Context

The company operates primarily in the U.S. cannabis industry, which is characterized by high capital intensity, limited access to traditional bank financing due to federal illegality, and ongoing state-level legalization. The strategic shift to a BDC and expanded investment mandate reflects an adaptation to these industry dynamics, aiming to diversify beyond real estate-backed cannabis loans to capture opportunities in non-real estate-covered cannabis operators and ancillary businesses, as well as other middle-market companies. This move acknowledges the capital constraints faced by many cannabis operators who do not own real estate and seeks to leverage the management team's broader direct lending experience.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• AFC Agent and the company commenced separate legal actions against two shareholders of the parent of Subsidiary of Private Company G in the U.S. District Court for the Southern District of New York, asserting claims for RICO violations, breach of shareholder guaranty, tortious interference with contract, fraud, aiding and abetting fraud, and conversion.
• The AFC Parties filed an amended complaint against the two shareholders of the parent of Subsidiary of Private Company G, asserting claims for breach of contract, tortious interference with contract, fraud, aiding and abetting fraud, and conversion.
• Two Subsidiary of Private Company G-affiliated cannabis companies filed a complaint in the U.S. District Court for the District of New Jersey against the AFC Parties, alleging breach of contract, breach of implied covenant of good faith and fair dealing, and violations of the New York Uniform Commercial Code.
• A preliminary injunction was granted against the company on May 9, 2025, enjoining it from seizing assets or seeking remedies for certain defaults by Subsidiary of Private Company G. The company has appealed this ruling.
• AFC Agent is actively pursuing judicial and non-judicial remedies against Private Company P following its payment defaults and placement on nonaccrual status.

Related Party Transactions

• The company is externally managed by AFC Management, LLC (the Manager), which receives base management fees and incentive compensation. Incentive compensation for the three and six months ended June 30, 2025, was zero due to lower Core Earnings, compared to $2.9 million and $5.3 million, respectively, in the prior year periods.
• The Manager is reimbursed for certain general and administrative expenses and professional fees incurred on behalf of the company.
• Amounts payable to the Manager as of June 30, 2025, were approximately $1.4 million.
• The Manager's equity is beneficially owned by certain officers and Tannenbaum family members, including Leonard Tannenbaum (Chairman) and Robyn Tannenbaum (President and Chief Investment Officer).
• The company may co-invest with other investment vehicles managed by the Manager or its affiliates.
• The AFCF Credit Facility, an unsecured revolving credit agreement with AFC Finance, LLC (an affiliate of the company and Mr. and Mrs. Tannenbaum), was terminated in April 2025 with no outstanding borrowings.

Stakeholder Impact

• **Shareholders**: Experienced a significant net loss, a decrease in book value per share, and a substantial reduction in dividends, indicating poor financial performance. The proposed BDC conversion and expanded investment strategy could offer long-term growth potential and diversification, but also introduces new risks and requires shareholder approval.
• **Borrowers**: Several key borrowers are on nonaccrual status, and the company is actively pursuing legal remedies against some, indicating strained relationships and potential for further defaults. The expanded investment strategy may open up new lending opportunities for a broader range of cannabis and non-cannabis businesses.
• **Employees/Manager**: The Manager's incentive fees were zero due to lower Core Earnings, directly impacting their compensation. The BDC conversion could lead to a broader scope of work and new opportunities for the management team.
• **Creditors**: The company's liquidity has significantly decreased, and there's an explicit statement about needing to raise additional capital, which could impact existing creditors' risk profiles. The increase in the current expected credit loss reserve suggests higher risk of non-payment from borrowers, which could indirectly affect the company's ability to service its own debt.

Next Steps

• File a preliminary proxy statement with the SEC to seek shareholder approval for the new Investment Advisory Agreement and a reduction in the asset coverage ratio for BDC operation.
• Mail definitive proxy statements to shareholders for the BDC conversion vote.
• The Board will consider other matters necessary to effect the conversion to a BDC in the coming months.
• Actively pursue judicial and non-judicial remedies against Private Company P following its default.
• Potentially enter into a new At-the-Market (ATM) program and related sales agreement in the future to sell shares under the Shelf Registration Statement.
• Raise additional equity and/or debt funds to increase liquidity and fund future investments.

Key Dates

Recommendation

The company's financial performance is significantly worse, marked by a substantial net loss, a sharp decline in interest income, and a dramatic increase in credit loss provisions. Liquidity has deteriorated, and dividends have been cut. While the strategic pivot to a BDC and expanded investment mandate offers a potential long-term growth path, the immediate operational challenges, including multiple nonaccrual loans and ongoing legal disputes with key borrowers, present considerable near-term risks and uncertainties. The current financial health and operational headwinds suggest a 'sell' recommendation for investors seeking stability or positive returns in the short to medium term, as the path to recovery and successful BDC transition is fraught with execution risk and potential further losses.

Keywords

Cannabis lending, SEC filing, 10-Q, REIT, BDC conversion, Loan portfolio, Credit losses, Nonaccrual loans, Financial results, Debt financing, Corporate governance, Risk management, Advanced Flower Capital